Protalix BioTherapeutics
PLX
#8447
Rank
HK$1.28 B
Marketcap
HK$17.41
Share price
3.23%
Change (1 day)
46.42%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -HK$60.82 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$45.66 Million. In 2023 the company made an earning of HK$91.36 Million, an increase over its 2022 earnings that were of -HK$92.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$60.82 Million-166.56%
2023 HK$91.36 M-199.05%
2022 -HK$92.25 Million-40.38%
2021 -HK$0.16 Billion-732.31%
2020 HK$24.46 M-130.53%
2019 -HK$80.14 Million189.85%
2018 -HK$27.65 Million-95.29%
2017 -HK$0.59 Billion308.12%
2016 -HK$0.15 Billion-32.37%
2015 -HK$0.22 Billion10.11%
2014 -HK$0.2 Billion-7.59%
2013 -HK$0.21 Billion
2011 -HK$0.25 Billion-19.39%
2010 -HK$0.31 Billion20.87%
2009 -HK$0.25 Billion32.26%
2008 -HK$0.19 Billion-5.46%
2007 -HK$0.2 Billion
2004 -HK$1.29 Million12.35%
2003 -HK$1.15 Million-11.1%
2002 -HK$1.29 Million-57.03%
2001 -HK$3 Million1.03%
2000 -HK$2.97 Million-53.22%
1999 -HK$6.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.23 Billion 270.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.98 B-6,716.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$53.96 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.2 Billion 3,534.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel